135 related articles for article (PubMed ID: 7664171)
1. Role of histamine in natural killer cell-dependent protection against herpes simplex virus type 2 infection in mice.
Hellstrand K; Asea A; Hermodsson S
Clin Diagn Lab Immunol; 1995 May; 2(3):277-80. PubMed ID: 7664171
[TBL] [Abstract][Full Text] [Related]
2. Histaminergic regulation of natural killer cell-mediated clearance of tumour cells in mice.
Asea A; Hermodsson S; Hellstrand K
Scand J Immunol; 1996 Jan; 43(1):9-15. PubMed ID: 8560202
[TBL] [Abstract][Full Text] [Related]
3. Role of histamine in natural killer cell-mediated resistance against tumor cells.
Hellstrand K; Asea A; Hermodsson S
J Immunol; 1990 Dec; 145(12):4365-70. PubMed ID: 2147942
[TBL] [Abstract][Full Text] [Related]
4. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
Bukowski JF; Welsh RM
J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
[TBL] [Abstract][Full Text] [Related]
5. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells.
Staats HF; Oakes JE; Lausch RN
J Virol; 1991 Nov; 65(11):6008-14. PubMed ID: 1920624
[TBL] [Abstract][Full Text] [Related]
6. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus.
Tsunobuchi H; Nishimura H; Goshima F; Daikoku T; Suzuki H; Nakashima I; Nishiyama Y; Yoshikai Y
Virology; 2000 Sep; 275(1):57-66. PubMed ID: 11017787
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells prevent direct anterior-to-posterior spread of herpes simplex virus type 1 in the eye.
Tanigawa M; Bigger JE; Kanter MY; Atherton SS
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):132-7. PubMed ID: 10634612
[TBL] [Abstract][Full Text] [Related]
8. Role of NK cells in protection of mice against herpes simplex virus-1 infection.
Rager-Zisman B; Quan PC; Rosner M; Moller JR; Bloom BR
J Immunol; 1987 Feb; 138(3):884-8. PubMed ID: 3805719
[TBL] [Abstract][Full Text] [Related]
9. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice.
Habu S; Akamatsu K; Tamaoki N; Okumura K
J Immunol; 1984 Nov; 133(5):2743-7. PubMed ID: 6207244
[TBL] [Abstract][Full Text] [Related]
10. In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis.
Adler H; Beland JL; Del-Pan NC; Kobzik L; Sobel RA; Rimm IJ
J Neuroimmunol; 1999 Jan; 93(1-2):208-13. PubMed ID: 10378885
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2.
Hellstrand K; Hermodsson S
Int Arch Allergy Appl Immunol; 1990; 92(4):379-89. PubMed ID: 2150668
[TBL] [Abstract][Full Text] [Related]
12. Protection of OK-432, a Streptococcus pyogenes preparation, against lethal infection of mice with herpes simplex virus.
Harada Y; Kurokawa E; Endo H; Kimura T; Saito M; Sugawara Y; Irie H; Ito K; Fujii M; Shimizu Y
Microbiol Immunol; 1989; 33(6):467-77. PubMed ID: 2549347
[TBL] [Abstract][Full Text] [Related]
13. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
14. Injection of anti-thy-1.2 serum breaks genetic resistance of mice against herpes simplex virus.
Chmielarczyk W; Engler H; Ernst R; Opitz U; Kirchner H
J Gen Virol; 1985 May; 66 ( Pt 5)():1087-94. PubMed ID: 2582081
[TBL] [Abstract][Full Text] [Related]
15. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1.
Rossol-Voth R; Rossol S; Schütt KH; Corridori S; de Cian W; Falke D
J Gen Virol; 1991 Jan; 72 ( Pt 1)():143-7. PubMed ID: 1703559
[TBL] [Abstract][Full Text] [Related]
16. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection.
Ghiasi H; Cai S; Perng GC; Nesburn AB; Wechsler SL
Antiviral Res; 2000 Jan; 45(1):33-45. PubMed ID: 10774588
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet.
Svensson A; Nordström I; Sun JB; Eriksson K
J Immunol; 2005 May; 174(10):6266-73. PubMed ID: 15879125
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of IFN-gamma in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol.
Carr DJ
J Neuroimmunol; 1998 Aug; 89(1-2):160-7. PubMed ID: 9726838
[TBL] [Abstract][Full Text] [Related]
19. Activity of the Keggin polyoxotungstate PM-19 against herpes simplex virus type 2 infection in immunosuppressed mice: role of peritoneal macrophage activation.
Ikeda S; Nishiya S; Yamamoto A; Yamase T; Nishimura C; De Clercq E
J Med Virol; 1993 Nov; 41(3):191-5. PubMed ID: 8263499
[TBL] [Abstract][Full Text] [Related]
20. Dual TLR2/9 Recognition of Herpes Simplex Virus Infection Is Required for Recruitment and Activation of Monocytes and NK Cells and Restriction of Viral Dissemination to the Central Nervous System.
Uyangaa E; Choi JY; Patil AM; Hossain FMA; Park SO; Kim B; Kim K; Eo SK
Front Immunol; 2018; 9():905. PubMed ID: 29760708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
